Part of the case against GlaxoSmithKline settled yesterday involved the company’s use of paid experts to promote non-FDA approved uses of its drugs. One expert, Dr. Drew Pinsky, was paid $275,000 over two months in 1999 to deliver messages about Wellbutrin “in settings where it did not appear that Dr. Pinsky was speaking for GSK.”
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.
Mad in America has made some changes to the commenting process. You no longer need to login or create an account on our site to comment. The only information needed is your name, email and comment text. Comments made with an account prior to this change will remain visible on the site.